After $80M NC expansion, pharma launches new drugs to be made at new facility

Australia ’s Mayne Pharma Group Limited is launching new drugs that will be made at its new manufacturing facility in Greenville. The pharma's latest launch is a generic alternative to Concordia International’s drug, Kapvay, for the treatment of attention deficit hyperactivity disorder.   Mayne Pharma cited contract research giant Iqvia in stating annual U.S. sales of the particular type of tablets “were approximately $60 million for the 12 months [ended] April 30, 2018.” Back in 2016,…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news